// App-Quantinova.ai

3653 : Mutational analysis of PARK2, a regulator of cyclin D1 stability, in sporadic parathyroid adenoma

Researchers

Presenter

  • Kelly Brewer

Principal Investigators

  • Jessica Costa-Guda

  • Andrew Arnold

Medical Centers

  • UCONN Health, Farmington, CT

  • University of Connecticut School of Medicine, Farmington, CT

  • University of Connecticut School of Medicine, Farmington, CT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Parathyroid adenoma

  • Solid malignancies

  • Parkinson disease 2

Biomarkers

  • Cyclin D1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved